OCM
Objective Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
1,815
-615
| -25% | -$77.8K | 0.26% | 74 |
|
|
2025
Q1 | $311K | Sell |
2,430
-30
| -1% | -$3.84K | 0.4% | 60 |
|
|
2024
Q4 | $325K | Sell |
2,460
-600
| -20% | -$79.3K | 0.22% | 100 |
|
|
2024
Q3 | $445K | Buy |
+3,060
| New | +$445K | 0.26% | 83 |
|
|
2024
Q1 | $399K | Buy |
2,909
+101
| +4% | +$13.9K | 0.27% | 80 |
|
|
2023
Q4 | $382K | Buy |
2,808
+650
| +30% | +$88.3K | 0.29% | 74 |
|
|
2023
Q3 | $264K | Hold |
2,158
| – | – | 0.23% | 84 |
|
|
2023
Q2 | $274K | Buy |
2,158
+12
| +0.6% | +$1.52K | 0.24% | 77 |
|
|
2023
Q1 | $277K | Buy |
2,146
+38
| +2% | +$4.91K | 0.25% | 73 |
|
|
2022
Q4 | $277K | Hold |
2,108
| – | – | 0.28% | 74 |
|
|
2022
Q3 | $247K | Hold |
2,108
| – | – | 0.26% | 75 |
|
|
2022
Q2 | $248K | Sell |
2,108
-1,071
| -34% | -$126K | 0.25% | 78 |
|
|
2022
Q1 | $414K | Buy |
3,179
+1
| +0% | +$130 | 0.32% | 71 |
|
|
2021
Q4 | $485K | Buy |
+3,178
| New | +$485K | 0.34% | 63 |
|